Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 30.08 | -17.78 |
| PEG Ratio (TTM) | 0.30 | -5.55 |
| P/S Ratio (TTM) | N/A | 39.43 |
| P/B Ratio (TTM) | -15,935,688.46 | 5.80 |
| P/FCF Ratio (TTM) | -207.52 | -146.47 |
| Price to 5YR AVG Earnings Ratio | N/A | -34.01 |
| Price to 5YR AVG FCF Ratio | N/A | -1.00 |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 800,388,981.31% | 288.99% |
| ROE (TTM) | 160,307.09% | -4,244.29% |
| Net Profit Margin (TTM) | N/A | -1,050.76% |
| ROIC 5YR AVG | N/A | -15.85% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 283.73% | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | 279.03% | N/A | N/A |
| Cash Flow | -16.64% | N/A | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | -193.64 | 4.94 |
| Quick Ratio (TTM) | -193.64 | 4.92 |
| D/E Ratio (TTM) | N/A | 1.30 |
| Interest Coverage (TTM) | 0.29 | -11.46 |
| Piotroski F-Score | 3 | 3 |
| Altman Z-Score | 17.27 | 21.03 |
| LTL to 5YR AVG FCF | N/A | -0.53 |
| Shares Outstanding Growth 5YR AVG | N/A | 892.04% |